1-5 of 5
Anne O'Neill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

Open Access
Glenn J. Hanna, Anne O'Neill, Kee-Young Shin, Kristine Wong, Vickie Y. Jo, Charles T. Quinn, Jennifer M. Cutler, Michelle Flynn, Patrick H. Lizotte, Donald J. Annino, Jr, Laura A. Goguen, Jason I. Kass, Eleni M. Rettig, Rosh K.V. Sethi, Jochen H. Lorch, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Peter C. Everett, Anupam M. Desai, Megan E. Cavanaugh, Cloud P. Paweletz, Ann Marie Egloff, Ravindra Uppaluri, Robert I. Haddad
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (3): 468–478.
https://doi.org/10.1158/1078-0432.CCR-21-2635
Published: 01 February 2022
View articletitled, Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

Free
Glenn J. Hanna, Naifa L. Busaidy, Nicole G. Chau, Lori J. Wirth, Justine A. Barletta, Antonio Calles, Robert I. Haddad, Stefan Kraft, Maria E. Cabanillas, Guilherme Rabinowits, Anne O'Neill, Sewanti A. Limaye, Erik K. Alexander, Francis D. Moore, Jr, Krystof Misiwkeiwicz, Tom Thomas, Matthew Nehs, Ellen Marqusee, Stephanie L. Lee, Pasi A. Jänne, Jochen H. Lorch
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1546–1553.
https://doi.org/10.1158/1078-0432.CCR-17-2297
Published: 02 April 2018
View articletitled, Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Open the PDF for Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure

Free
Bryan P. Schneider, Fei Shen, Laura Gardner, Milan Radovich, Lang Li, Kathy D. Miller, Guanglong Jiang, Dongbing Lai, Anne O'Neill, Joseph A. Sparano, Nancy E. Davidson, David Cameron, Irmina Gradus-Pizlo, Ronald A. Mastouri, Thomas M. Suter, Tatiana Foroud, George W. Sledge, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 43–51.
https://doi.org/10.1158/1078-0432.CCR-16-0908
Published: 02 January 2017
View articletitled, Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Open the PDF for Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Free
Bryan P. Schneider, Lang Li, Milan Radovich, Fei Shen, Kathy D. Miller, David A. Flockhart, Guanglong Jiang, Gail Vance, Laura Gardner, Matteo Vatta, Shaochun Bai, Dongbing Lai, Daniel Koller, Fengmin Zhao, Anne O'Neill, Mary Lou Smith, Elda Railey, Carol White, Ann Partridge, Joseph Sparano, Nancy E. Davidson, Tatiana Foroud, George W. Sledge, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5082–5091.
https://doi.org/10.1158/1078-0432.CCR-15-0586
Published: 12 November 2015
View articletitled, Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
Open the PDF for Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199 in another window
Includes: Supplementary data
Journal Articles

A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer

Free
Carlos L. Arteaga, Anne O'Neill, Stacy L. Moulder, Michael Pins, Joseph A. Sparano, George W. Sledge, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6277–6283.
https://doi.org/10.1158/1078-0432.CCR-08-0482
Published: 30 September 2008
View articletitled, A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer
Open the PDF for A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer in another window